Market News

FedEx Freight Holding Company, Inc. (NYSE:FDXF) was among the stocks Jim Cramer discussed during Mad Money, as he called the growing wave of stock off...

The U.K. government designated Microsoft, Alphabet, Amazon and Oracle as Critical Third Parties to strengthen and safeguard the country’s financial sy...

One trades at a steep discount on valuation metrics; the other commands a premium for its digital-first model and cash generation.

GE Vernova remains foundational to the AI and electrification boom, boasting a massive multi-year backlog. Check out why GEV stock is a hold.

The chipmaker's premium valuation melts away when you look at what analysts expect it to earn, but that discount depends entirely on the growth arrivi...

A look at the company's history of deep drawdowns shows the real risk shareholders are carrying today.

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry ...

Tim Cook inherited Steve Jobs's shadow and a skeptical Wall Street, then quietly engineered one of the most stunning wealth-creation runs in stock mar...

PepsiCo's Q2 revenue topped estimates and guidance was reaffirmed despite margin pressure, with analysts holding a Hold rating as the stock trades bel...

Nuclear energy is a multi-decade growth opportunity.

Omnia Training has been awarded a £2bn contract by the UK Ministry of Defence to serve as the British Army's Strategic Training Partner and deliver th...

The streamer may be exploring a pivot away from its roots in a bid to boost engagement and revive its faltering shares.

The apparel company tapped beauty industry veteran Kathleen Van Nest Pierce, effective in August.

The carrier reported adjusted earnings per share of $1.56 on revenue of $19.8 billion. Analysts were expecting EPS of $1.49 on revenue of $17.5 billio...

Circle Internet shares jump after the company says it won regulatory approval to establish a crypto national trust bank.

Ionis and AstraZeneca's Phase 3 ATTR-CM trial misses its primary goal, analyst says the outcome favors existing and next-gen therapies.

UnitedHealth Group (NYSE:UNH) carries the highest conviction among managed care names heading into the company’s July 16 earnings report, and the setu...